| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 67,357 | 115,496 | 156,048 | | Cost of Revenue | 38,469 | 62,565 | 88,210 | | | Gross Profit | 28,888 | 52,931 | 67,838 | | | Operating Expenses | | Research Development | 50,134 | 47,397 | 45,912 | | Selling General and Administrative | 22,749 | 37,021 | 52,396 | | Non Recurring | 27,809 | 6,814 | 28,970 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (71,804) | (38,301) | (59,440) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,000 | 38,784 | 47,089 | | Earnings Before Interest And Taxes | (53,804) | 483 | (12,351) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (53,804) | 483 | (12,351) | | Income Tax Expense | (232) | 597 | 854 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (53,572) | (114) | (13,205) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (53,572) | (114) | (13,205) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($53,572) | ($114) | ($13,205) |
|
1.48% Nasdaq 
Income Statement
